UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34 + Cells in Healthy Volunteers

Clinical cancer research, 2017-11, Vol.23 (22), p.6790-6801

2017

Volltextzugriff (PDF)

Real-world experience with the IUB Ballerine MIDI copper IUD: an observational, single-centre study in Israel

The European journal of contraception & reproductive health care, 2020-01, Vol.25 (1), p.49-53

2020

Volltextzugriff (PDF)

Real-world experience with the IUB Ballerine MIDI copper IUD: an observational study in the French-speaking region of Switzerland

The European journal of contraception & reproductive health care, 2019-07, Vol.24 (4), p.288-293

2019

Volltextzugriff (PDF)

A blocking monoclonal antibody to CCL24 alleviates liver fibrosis and inflammation in experimental models of liver damage

JHEP reports, 2020-02, Vol.2 (1), p.100064-100064, Article 100064

2020

Volltextzugriff (PDF)

Novel approach combining whole liver single-cell RNA sequencing and spatial gene profiling using Nanostring GEOMX enables identification of specific cell sub-populations and pathways regulated by CCL24

Journal of hepatology, 2022-07, Vol.77, p.S27-S28

2022

Volltextzugriff (PDF)

A Novel Proliposomal Ropivacaine Oil: Pharmacokinetic–Pharmacodynamic Studies After Subcutaneous Administration in Pigs

Anesthesia and analgesia, 2016-05, Vol.122 (5), p.1663-1672

2016

Volltextzugriff (PDF)

CCL24 modulates fibrosis development in primary sclerosing cholangitis: correlation of human serum CCL24 levels with fibrosis markers and data from the Mdr2–/– mouse model

Journal of hepatology, 2020-08, Vol.73, p.S486

2020

Volltextzugriff (PDF)

FRI174 - CCL24 modulates fibrosis development in primary sclerosing cholangitis: correlation of human serum CCL24 levels with fibrosis markers and data from the Mdr2–/– mouse model

Journal of hepatology, 2020-08, Vol.73, p.S486-S486

2020

Volltextzugriff (PDF)

Proliposomal Ropivacaine Oil: Pharmacokinetic and Pharmacodynamic Data After Subcutaneous Administration in Volunteers

Anesthesia and analgesia, 2016-05, Vol.122 (5), p.1673-1680

2016

Volltextzugriff (PDF)

Abstract 674: Novel anti-cancer small molecule targeting the protein regulator of cytokinesis pathway

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.674-674

2024

Volltextzugriff (PDF)

THU-022-CM-101-a Novel anti CCL24 monoclonal antibody reduces cholangiocytes proliferation in experimental cholestasis models

Journal of hepatology, 2019-04, Vol.70 (1), p.e169-e170

2019

Volltextzugriff (PDF)

Effect of BL-8040, high-affinity CXCR4 antagonist, on T-cell infiltration, tumor growth, and synergy with immunomodulatory agents

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e14544-e14544

2017

Volltextzugriff (PDF)

Abstract 2329: A Randomized Double Blind, Placebo controlled Phase 1a Clinical Trial of THR-18, a PAI-1 Derived peptide, in Normal Volunteers

Stroke (1970), 2012-02, Vol.43 (suppl_1)

2012

Volltextzugriff (PDF)

Prolonged Analgesic Effect of PRF-108 and PRF-110 on Post-operative Pain in Pigs

Pain and therapy, 2016-06, Vol.5 (1), p.29-42

2016

Volltextzugriff (PDF)

Final Phase IIa Study Results Evaluating the CXCR4 Antagonist BL-8040 in Combination with Cytarabine (Ara-C) for the Treatment of Relapsed/Refractory AML Patients

Clinical lymphoma, myeloma and leukemia, 2016-09, Vol.16, p.S28-S28

2016

Volltextzugriff (PDF)

BL-8040, A novel CXCR4 inhibitor, affects AML blasts survival and induces their terminal differentiation

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.S12-S12

2015

Volltextzugriff (PDF)

Primary pterygium recurrence time

The Israel Medical Association journal, 2001-11, Vol.3 (11), p.836-837

2001

Volltextzugriff (PDF)

Simulation of laser-induced tunnel ionization based on a curved waveguide

Scientific reports, 2023-08, Vol.13 (1), p.12612-12612, Article 12612

2023

Volltextzugriff (PDF)

CaGLK2 regulates natural variation of chlorophyll content and fruit color in pepper fruit

Theoretical and applied genetics, 2014-10, Vol.127 (10), p.2139-2148

2014

Volltextzugriff (PDF)

Challenges of oral immunotherapy for food allergy during a national crisis

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2024-05, Vol.12 (5), p.1382-1383

2024

Volltextzugriff (PDF)

Glycemic outcomes and patient satisfaction and self-management improves in transition from standard to virtual multidisciplinary care

Diabetes research and clinical practice, 2024-03, Vol.209, p.111587-111587, Article 111587

2024

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(68)
Tagungsberichte
(2)

Sprache

Englisch
(68)
Hebräisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34 + Cells in Healthy Volunteers

Real-world experience with the IUB Ballerine MIDI copper IUD: an observational, single-centre study in Israel

BL‐8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open‐label safety and efficacy phase 2a study

Real-world experience with the IUB Ballerine MIDI copper IUD: an observational study in the French-speaking region of Switzerland

A blocking monoclonal antibody to CCL24 alleviates liver fibrosis and inflammation in experimental models of liver damage

Novel approach combining whole liver single-cell RNA sequencing and spatial gene profiling using Nanostring GEOMX enables identification of specific cell sub-populations and pathways regulated by CCL24

A Novel Proliposomal Ropivacaine Oil: Pharmacokinetic–Pharmacodynamic Studies After Subcutaneous Administration in Pigs

CCL24 modulates fibrosis development in primary sclerosing cholangitis: correlation of human serum CCL24 levels with fibrosis markers and data from the Mdr2–/– mouse model

FRI174 - CCL24 modulates fibrosis development in primary sclerosing cholangitis: correlation of human serum CCL24 levels with fibrosis markers and data from the Mdr2–/– mouse model

Proliposomal Ropivacaine Oil: Pharmacokinetic and Pharmacodynamic Data After Subcutaneous Administration in Volunteers

Abstract 674: Novel anti-cancer small molecule targeting the protein regulator of cytokinesis pathway

THU-022-CM-101-a Novel anti CCL24 monoclonal antibody reduces cholangiocytes proliferation in experimental cholestasis models

Effect of BL-8040, high-affinity CXCR4 antagonist, on T-cell infiltration, tumor growth, and synergy with immunomodulatory agents

Abstract 2329: A Randomized Double Blind, Placebo controlled Phase 1a Clinical Trial of THR-18, a PAI-1 Derived peptide, in Normal Volunteers

Prolonged Analgesic Effect of PRF-108 and PRF-110 on Post-operative Pain in Pigs

The Selective Anti Leukemic Effect of BL-8040, a Peptidic CXCR4 Antagonist, Is Mediated By Induction of Leukemic Blast Mobilization, Differentiation and Apoptosis: Results of Correlative Studies from a Ph2a Trial in Acute Myeloid Leukemia

The Peptidic CXCR4 Antagonist, BL-8040, Significantly Reduces Bone Marrow Immature Leukemia Progenitors By Inducing Differentiation, Apoptosis and Mobilization: Results of the Dose Escalation Clinical Trial in Acute Myeloid Leukemia

BL-8040, a Peptidic CXCR4 Antagonist, Induces Leukemia Cell Death and Specific Leukemia Cell Mobilization in Relapsed/Refractory Acute Myeloid Leukemia Patients in an Ongoing Phase IIa Clinical Trial

Final Phase IIa Study Results Evaluating the CXCR4 Antagonist BL-8040 in Combination with Cytarabine (Ara-C) for the Treatment of Relapsed/Refractory AML Patients

BL-8040, A novel CXCR4 inhibitor, affects AML blasts survival and induces their terminal differentiation

Primary pterygium recurrence time

Simulation of laser-induced tunnel ionization based on a curved waveguide

CaGLK2 regulates natural variation of chlorophyll content and fruit color in pepper fruit

Challenges of oral immunotherapy for food allergy during a national crisis

Glycemic outcomes and patient satisfaction and self-management improves in transition from standard to virtual multidisciplinary care

Suchergebnisse filtern